Associate Professor of Surgery
Harvard Medical School
Boston, Massachusetts, United States
Anahita Dua, MD, MS, MBA, FACS, is a vascular surgeon at Massachusetts General Hospital and an Associate professor of Surgery at Harvard Medical School. She is the director of the Vascular Lab, co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program (LEAPP), associate director of the Wound Care Center, and associate director of the Vascular Surgery Clerkship. She specializes in advanced endovascular (minimally invasive) and traditional (open) limb salvage techniques for treating peripheral arterial disease and critical limb ischemia. Dr. Dua completed her vascular surgery fellowship at Stanford. She is board-certified in vascular & general surgery. Dr. Dua has published over 150 peer reviewed papers; her lab focuses on anticoagulation and biomarkers that are predictive of thrombosis and hemostasis in patients that have undergone revascularization.
Sunday, February 26, 2023
1:00 PM – 2:00 PM ET
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (Ongoing); Gore: Consultant (Ongoing)
Monday, February 27, 2023
6:15 AM – 7:50 AM ET
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (Ongoing); Gore: Consultant (Ongoing)
Monday, February 27, 2023
9:40 AM – 12:00 PM ET
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (Ongoing); Gore: Consultant (Ongoing)
Monday, February 27, 2023
9:40 AM – 10:40 AM ET
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (Ongoing); Gore: Consultant (Ongoing)
Monday, February 27, 2023
11:36 AM – 11:44 AM ET
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (Ongoing); Gore: Consultant (Ongoing)
Monday, February 27, 2023
11:44 AM – 12:00 PM ET
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (Ongoing); Gore: Consultant (Ongoing)
Monday, February 27, 2023
5:00 PM – 6:00 PM ET
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (Ongoing); Gore: Consultant (Ongoing)
Monday, February 27, 2023
5:05 PM – 5:40 PM ET
Disclosure information not submitted.